BriaCell Therapeutics Corp. (BCTX) NASDAQ
3.27
-0.04(-1.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.27
-0.04(-1.21%)
Currency In USD
Address
Bellevue Centre
West Vancouver, BC V7T 2X1
Canada
Phone
604 921 1810
Website
Sector
Healthcare
Industry
Biotechnology
Employees
16
First IPO Date
March 14, 2012
| Name | Title | Pay | Year Born |
| William V. Williams | Chief Executive Officer, President & Director | 711,724 | 1955 |
| Charles Louis Wiseman FACP | Founder, Principal Research Advisor & Member of Scientific Advisory Board | 241,138 | 1947 |
| Miguel A. Lopez-Lago | Chief Scientific Officer | 447,547 | 1970 |
| Giuseppe Del Priore | Chief Medical Officer | 493,048 | 1962 |
| Gadi Levin | Chief Financial Officer & Corporate Secretary | 535,361 | 1973 |
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.